I am working on creating a vocabulary for a set of cancer treatment regimens (similar to HemOnc vocabulary)
My question is just to get a sense of the wisdom of defining these regimens at a significantly higher granularity than HemOnc, whereby we would want to define not only the drugs that belong to a given regimen, but also their dosage and schedule.
The goal of getting more specific is in measuring unwarranted variation from the specified protocol (e.g. underdosing, changes in schedule), so there is a specific reason for wanting to spell out precisely the how and when, not just the what of each protocol, but since it introduces more complexity than I could find in similar concepts and vocabularies, I was hoping there would be someone who had achieved (or come up against a road-block to achieving) similar goals to give some guidance before I head too far down that path however.
The draft definition for the treatment protocol looks something like this (chemotherapy example - only partially transcribed - NB ~ placeholder for fields not relevant for this protocol just to give an idea of the full set of fields).
The idea is that a protocol may be made up of one or more regimens. Regimens typically defined as treatment phases (Induction / Consolidation / Maintenance) across a protocol.
- Protocol (Autologous conditioning protocol germ cell tumour TICE treatment overview)
- Regimen (Autologous conditioning protocol germ cell tumour TICE (PACLItaxel and IFOSFamide) (part 1)
- Has intent (~)
- Has type (~)
- Has indication (Relapsed and refractory metastatic germ cell tumours)
- Has contra-indication (~)
- Has cycles (2)
- Has frequency (14 days)
- Has duration (~)
- Has treatment Session (session name tbd)
- Is scheduled on day (1)
- Has treatment (treatment name tbd)
- Drug (Loratadine)
Dose (10 mg)
Route (Oral)
Form (~)
- Drug (Loratadine)
- Has treatment (treatment name tbd)
- Drug (Ranitidine)
Dose (50 mg)
Route (IV)
- Drug (Ranitidine)
- Has treatment (treatment name tbd)
- Drug (Dexamethasone)
Dose (20 mg)
Route (IV)
- Drug (Dexamethasone)
- Regimen (Autologous conditioning protocol germ cell tumour TICE (PACLItaxel and IFOSFamide) (part 1)